NOT-DK-21-011: Notice to Extend the Expiration Date for PAR-19-222, "Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)"

Notice to Extend the Expiration Date for PAR-19-222, "Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)"

Notice Number:

NOT-DK-21-011

Key Dates

Release Date:

February 3, 2021

Related Announcements

PAR-19-222 - Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this Notice is to extend the expiration date for PAR-19-222, "Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)". The extension of PAR-19-222 accommodates receipt of new applications on June 16, 2021, resubmission applications on July 16, 2021, and AIDS applications on September 7, 2021. Due to the extension, PAR-19-222 will now expire on September 8, 2021.

The following section of the FOA has been changed:

Part 1. Overview Information

Key Dates

Currently reads:

Expiration Date: May 8, 2021

Modified to read (changes shown in bold italics):

Expiration Date: September 8, 2021

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Katrina J. Serrano, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Email: [email protected]